毒素-抗毒素系统突变与MDR-TB的全球传播之间的关联
Yameng Li1,2, Yang Shao1, Yifan Li3
1Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
BMC infectious diseases
|November 5, 2024
概括
毒素-抗毒素系统基因的突变显著推动了多药耐药结核病 (MDR-TB) 的全球传播. 识别这些基因突变为控制全球MDR-TB传播提供了新的策略.
科学领域:
- 基因组学就是基因组学.
- 微生物学 微生物学
- 流行病学 流行病学
背景情况:
- 抗药性结核病 (MDR-TB) 是全球卫生面临的一个重大挑战.
- 了解驱动MDR-TB传播的遗传因素对于有效控制至关重要.
研究的目的:
- 研究毒素-抗毒素 (TA) 系统基因突变在MDR-TB的全球传播中的作用.
- 为了识别与MDR-TB传播集群和分类相关的特定TA基因突变.
主要方法:
- 13,518个Mycobacterium结核病菌分离物的全基因组测序.
- 来自NCBI基因数据库的TA系统基因的分析.
- 机器学习 (随机森林,梯度提升) 和统计模型 (GLMMs) 的应用,以精确定位与传播相关的突变.
主要成果:
- 30.08%的分离物被确定为MDR-TB菌株.
- 在特定TA基因的突变 (例如Rv0298,Rv1959c,Rv1960c,Rv1991A,Rv2547,Rv2862A,Rv3385c) 和MDR-TB传播之间发现了显著的关联.
- 在Rv1956,Rv1960c和Rv1962A的突变与MDR-TB传染基因相关,其中一些与跨区域传播相关.
结论:
- 特定的毒素-抗毒素系统基因突变与全球MDR-TB传播有显著的关联.
- 结果为开发针对性干预针对MDR-TB提供了关键的见解.
相关概念视频
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis II
212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mismatch Repair
39.9K
Overview
39.9K
Pulmonary Tuberculosis III
305
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
305


